Virtual Academy Webinars
Do you know the Heidelberg Engineering Virtual Academy?
The Virtual Academy Program offers you various digital learning materials, which you can use to further educate yourself anytime and anywhere. Which topic is exciting for you? Here you will find information on all upcoming live formats of the Heidelberg Engineering Virtual Academy: webinars, live workshops and virtual symposia. Take the opportunity to attend a live presentation and address your questions directly to our experts.
The role of screening for sickle cell retinopathy in the medical management of sickle cell disease
Tuesday, November 2 | 6:30 pm – 7:30 pm (GMT)
Sickle cell disease is well known to cause peripheral retinal damage, but intervention is uncommon because problems such as new vessel growth will often settle without treatment. Vision can be affected by macular capillary closure, which can go unrecognised until vision is damaged. Whilst no eye treatment may be required, such findings can lead to additional treatment of the sickle cell disease to try and reduce further retinal and other end organ damage. This webinar will present a method of providing sickle cell retinopathy screening, in what can be a hard to reach group, using widefield colour, OCT, and OCTA imaging and an update on the medical management of sickle cell disease.
The role of screening for sickle cell retinopathy in the medical management of sickle cell disease: Brigit Greystoke, Consultant Haematologist
Overview of sickle cell retinopathy: Isabelle Mueller, Medical Retina Fellow
The use of widefield imaging, OCT, and OCTA in screening sickle cell retinopathy: James Talks, Consultant Ophthalmologist
Speaker: Dr. Brigit Greystoke, Isabelle Mueller, James Talks | Newcastle Eye Centre, Royal Victoria Infirmary
Neuroinflammatory disease and OCT
Wednesday, December 1 | 6:30 pm – 7:30 pm (GMT)
The background to this case-based seminar will present optic neuritis as the key ophthalmology clinical sign of neuro-inflammation. Optic neuritis may be idiopathic, related to multiple sclerosis (MS) or seen in neuromyelitis optica spectrum disorders
(NMOSD). Baseline and follow-up assessments using the OCT retinal nerve fibre layer and ganglion cell analysis are now currently used in neuro-ophthalmology to help distinguish early indicators of the underlying neuro-inflammatory pathology.
This can help guide treatment decisions in the acute setting. Longitudinal monitoring of OCT analysis of the optic nerve and the ganglion cell layer is becoming essential for those with MS, and may in the future inform physicians to escalate
second-line therapy. Whilst practical translation of machine learning research is some way off we will explore how important baseline OCT may be for predicting MS, but also informing on long-term disability.
Speaker: Susan Mollan, Consultant Neuro-Ophthalmologist | University Hospitals Birmingham NHSFT
The value of multimodal imaging in the diagnosis of posterior pole pathology
Wednesday, 2nd March 2022 | 6:30pm-7:30pm (GMT)
This webinar will discuss how the effective use of multimodal imaging (OCT, enhanced depth imaging, autofluorescence, near infrared, blue, red and green reflectance) in virtual clinics with a multidisciplinary team, allows accurate diagnosis of posterior pole pathology without the need for face-to-face consultation.
Speaker: Luke Carine, senior ophthalmic science practitioner